(19)
(11) EP 4 415 814 A2

(12)

(88) Date of publication A3:
03.08.2023

(43) Date of publication:
21.08.2024 Bulletin 2024/34

(21) Application number: 22887945.8

(22) Date of filing: 17.10.2022
(51) International Patent Classification (IPC): 
A61N 5/10(2006.01)
A61M 36/14(2006.01)
A61K 51/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 2005/1094; A61N 5/1029
(86) International application number:
PCT/US2022/046923
(87) International publication number:
WO 2023/076068 (04.05.2023 Gazette 2023/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.10.2021 US 202117503350
13.09.2022 US 202263405890 P

(71) Applicants:
  • Brooks, Kenneth, Wesley
    Roswell, GA 30076 (US)
  • Carter, Zachary, Gray
    Woodstock, GA 30188 (US)
  • Asbury, E,J, III
    Marietta, GA 30068 (US)

(72) Inventors:
  • Brooks, Kenneth, Wesley
    Roswell, GA 30076 (US)
  • Carter, Zachary, Gray
    Woodstock, GA 30188 (US)
  • Asbury, E,J, III
    Marietta, GA 30068 (US)

(74) Representative: WP Thompson 
8th Floor 1 Mann Island
Liverpool L3 1BP
Liverpool L3 1BP (GB)

   


(54) OPTIMIZATION OF RADIONUCLIDES FOR TREATMENT OF CUTANEOUS LESIONS